Only 5% of Wernicke encephalopathy cases are diagnosed before death, yet the condition is fatal in 20% of untreated patients and leads to Korsakoff syndrome in over half of survivors.

A multicenter trial reports that adding middle meningeal artery embolization to surgical evacuation reduced reoperation rates from 11.3% to 4.1% in subdural hematoma patients, though further safety evaluation is needed.

Phase 2a clinical trials demonstrate benfotiamine’s ability to enhance synaptic activity while maintaining an excellent safety profile, even at doses exceeding normal thiamine blood levels.

23 million Americans take levothyroxine daily, making it one of the nation’s most prescribed medications, with new evidence suggesting potential risks to bone health even at standard therapeutic levels.

The discovery of I-NCMs’ ability to simultaneously patrol blood vessels and infiltrate tumor environments opens new possibilities for treating therapy-resistant cancers.

Mortality rates for hiatal hernia repairs vary significantly between elective (1.3%) and emergency (8%) procedures, emphasizing the importance of timely intervention when complications arise.